Facts and fiction in the pharmacologic prevention of post-ERCP pancreatitis: a never-ending story

Gastrointestinal Endoscopy

Volumn 64, Issue 5, 2006, Pages 732-734

  Testoni, Pier Alberto ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OCTREOTIDE;

ACUTE PANCREATITIS; DRUG EFFICACY; EDITORIAL; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME ACTIVATION; ENZYME BLOOD LEVEL; HUMAN; PATIENT SELECTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SAMPLE SIZE; SURGICAL RISK;

BILIARY TRACT DISEASES; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GASTROINTESTINAL AGENTS; HUMANS; INCIDENCE; JAUNDICE, OBSTRUCTIVE; OCTREOTIDE; PANCREATIC NEOPLASMS; PANCREATITIS, ACUTE NECROTIZING;

EID: 33749995787     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gie.2006.07.004     Document Type: Editorial

References (30)

1. Tamas G., Tullassay Z., Papp J., et al. Effect of somatostatin on the pancreatic-like biochemical changes due to endoscopic pancreatography: a preliminary report. Metabolism 27 (1978) 1333-1336
2. Murray B., Carter R., Imrie C., et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangio-pancreatography. Gastroenterology 124 (2003) 1786-1791
3. Cavallini G., Tittobello A., Frulloni L., et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangio-pancreatography. N Engl J Med 335 (1996) 919-923
4. Deviere J., Le Moine O., Van Laethen J.L., et al. Interleukin-10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 120 (2001) 498-505
5. Raty S., Sand J., Pulkkinen M., et al. Post-ERCP pancreatitis: reduction by routine antibiotics. J Gastroenterol Surg 5 (2001) 339-345
6. Sudhindran S., Bromwich E., and Edwards P.R. Prospective randomized double-blind trial of glyceryl trinitrate in endoscopic retrograde cholangiopancreatography-induced pancreatitis. Br J Surg 88 (2001) 1178-1182
7. Rabenstein T., Roggenbuck S., Framke B., et al. Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis following endoscopic retrograde cholangio-pancreatography?. Gastrointest Endosc 55 (2002) 476-483
8. Moreto M., Zaballa M., Casado I., et al. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: a randomized double-blind trial. Gastrointest Endosc 57 (2003) 1-7
9. Poon R.T., Yeung C., Liu C.L., et al. Intravenous bolus somatostatin after diagnostic cholangio-pancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomized controlled trial. Gut 52 (2003) 1768-1773
10. Masci E., Cavallini G., Mariani A., et al. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis. Am J Gastroenterol 98 (2003) 2182-2186
11. Arvanitidis D., Anagnostopoulos G.K., Giannopoulos D., et al. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized controlled trial. J Gastroenterol Hepatol 19 (2004) 278-282
12. Gorelick A., Barnett J., Chey W., et al. Botulinum toxin injection after biliary sphincterotomy. Endoscopy 36 (2004) 170-173
13. Katsinelos P., Kountouras J., Chatzis J., et al. High-dose allopurinol for prevention of post-ERCP pancreatitis: a prospective randomized double-blind controlled trial. Gastrointest Endosc 61 (2005) 407-415
14. Tsujino T., Komatsu Y., Isayama H., et al. Ulinastatin for pancreatitis after endoscopic retrograde cholangio-pancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol 3 (2005) 376-383
15. Xiong G.S., Wu S.M., Zhang X.W., et al. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangio-pancreatography pancreatitis. Braz J Med Biol Res 39 (2006) 85-90
16. Thomopoulos K.C., Pagoni N.A., Vagenas K.A., et al. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Gastrointest Endosc 64 (2006) 726-731
17. Testoni P.A., Mariani A., Masci E., et al. Frequency of post-ERCP pancreatitis in a single tertiary referral center without and with routine prophylaxis with gabexate: a six-year survey. Dig Liv Dis 38 (2006) 588-595
18. Freeman M.L., Di Sario J.A., Nelson D.B., et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc 54 (2001) 425-434
19. Freeman M.L. Post-ERCP pancreatitis: patient- and technique-related risk factors. JOP 3 (2002) 169-176
20. Masci E., Mariani A., Curioni S., et al. Risk factors for pancreatitis following endoscopic retrograde cholangio-pancreatography: a meta-analysis. Endoscopy 35 (2003) 830-834
21. Rabenstein T., and Hahn E.G. Post-ERCP pancreatitis: is the endoscopist's experience the major risk factor?. JOP 3 (2002) 177-187
22. Rashdan A., Fogel E.L., McHenry L., et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol 2 (2004) 322-329
23. Testoni P.A., Bagnolo F., Andriulli A., et al. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial. Aliment Pharmacol Ther 15 (2001) 965-972
24. Andriulli A., Solmi L., Loperfido S., et al. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate. Clin Gastroenterol Hepatol 2 (2004) 713-718
25. Sherman S., Chen C.L., Costamagna G., et al. Efficacy of recombinant human interleukin-10 in prevention of acute pancreatitis after ERCP in subjects with increased risk: randomized, prospective multicenter study. [abstract]. Gastroenterology 128 (2005) Sp119
26. Andriulli A., Leandro G., Niro G., et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis. Gastrointest Endosc 51 (2000) 1-7
27. Andriulli A., Caruso N., Quitadamo M., et al. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study. JOP 4 (2003) 41-48
28. Lung E. The use of somatostatin or octreotide to prevent post-ERCP pancreatitis: a meta-analysis of randomized, controlled trials. [abstract]. Gastrointest Endosc 59 (2004) AB107
29. Gullo L., Pezzilli R., Ancona D., et al. Effect of octreotide, a long-acting somatostatin analogue, on plasma amino acid uptake by the pancreas. Pancreas 6 (1991) 668-672
30. Malfertheiner P., Mayer D., Buechler M., et al. Treatment of pain in chronic pancreatitis by inhibition of pancreatic secretion with octreotide. Gut 36 (1995) 450-454